Results

Total Results: 3,392 records

Showing results for "hypertension".
Users also searched for: diabetes

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_executive.pdf
    May 01, 2013 - to coronary artery disease and shares similar risk factors: male gender, age, diabetes, smoking, hypertension … inhibitors and the management of other risk factors such as tobacco use, diabetes, LDL levels, and hypertension … diabetes (two studies), and one study each on smoking status, vessel patency, sex, hyperlipidemia, hypertension … , when more effective medical treatments such as statins, ACE inhibitors, and adequate control of hypertension
  2. hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2018_Core_Weighted.PDF
    January 01, 2018 - 27,810 0.08% 302: ATHEROSCLEROSIS W MCC 8,315 0.02% 303: ATHEROSCLEROSIS W/O MCC 35,935 0.10% 304: HYPERTENSION … W MCC 41,155 0.12% 305: HYPERTENSION W/O MCC 99,650 0.28% 306: CARDIAC CONGENITAL & VALVULAR DISORDERS
  3. hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2018_Core.PDF
    January 01, 2018 - 5,562 0.08% 302: ATHEROSCLEROSIS W MCC 1,663 0.02% 303: ATHEROSCLEROSIS W/O MCC 7,187 0.10% 304: HYPERTENSION … W MCC 8,231 0.12% 305: HYPERTENSION W/O MCC 19,930 0.28% 306: CARDIAC CONGENITAL & VALVULAR DISORDERS
  4. hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2019_Core_Weighted_V2.PDF
    January 01, 2019 - 25,855 0.07% 302: ATHEROSCLEROSIS W MCC 7,905 0.02% 303: ATHEROSCLEROSIS W/O MCC 33,140 0.09% 304: HYPERTENSION … W MCC 42,325 0.12% 305: HYPERTENSION W/O MCC 102,875 0.29% 306: CARDIAC CONGENITAL & VALVULAR DISORDERS
  5. hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2017_Core_Weighted.PDF
    January 01, 2017 - 31,190 0.09% 302: ATHEROSCLEROSIS W MCC 8,306 0.02% 303: ATHEROSCLEROSIS W/O MCC 36,894 0.10% 304: HYPERTENSION … W MCC 37,983 0.11% 305: HYPERTENSION W/O MCC 103,597 0.29% 306: CARDIAC CONGENITAL & VALVULAR DISORDERS
  6. hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2016_Core_Weighted.PDF
    January 01, 2016 - 35,152 0.10% 302: ATHEROSCLEROSIS W MCC 8,364 0.02% 303: ATHEROSCLEROSIS W/O MCC 39,173 0.11% 304: HYPERTENSION … W MCC 15,157 0.04% 305: HYPERTENSION W/O MCC 78,245 0.22% 306: CARDIAC CONGENITAL & VALVULAR DISORDERS
  7. hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2018_Core_Weighted.PDF
    January 01, 2018 - 27,331 0.08% 302: ATHEROSCLEROSIS W MCC 7,781 0.02% 303: ATHEROSCLEROSIS W/O MCC 34,166 0.10% 304: HYPERTENSION … W MCC 41,485 0.12% 305: HYPERTENSION W/O MCC 103,919 0.29% 306: CARDIAC CONGENITAL & VALVULAR DISORDERS
  8. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_Weighted_V2.PDF
    January 01, 2019 - .**% 303: ATHEROSCLEROSIS W/O MCC 94 0.00% 304: HYPERTENSION W MCC 448 0.01% 305: HYPERTENSION W/O
  9. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2016_MaskedStats_Core_Weighted.PDF
    January 01, 2016 - .**% 303: ATHEROSCLEROSIS W/O MCC 88 0.00% 304: HYPERTENSION W MCC 193 0.00% 305: HYPERTENSION W/O
  10. www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/building-capacity/en-bsc-interim-report-1.pdf
    January 31, 2024 - Walunas (NU), as well as subject matter experts on hypertension and tobacco cessation representing the … net practices to improve blood pressure control and reduce heart health disparities by implementing hypertension … CardiOH lead CWRU has also worked to address hypertension through QI initiatives with eight high-volume … providers Qsource Cooperative focus Implementation of heart health interventions with a focus on hypertension … HHOI’s value proposition to practices and providers highlighted the high number of people with hypertension
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_disposition-comments.pdf
    September 15, 2014 - Page 255 It appears that this update found no new studies on the combined effect of vitamin D and hypertension … These bone-related sections are separated by sections on non-bone related outcomes (mortality, and hypertension … It is not clear why the bone-related variables were separated in this manner, especially since hypertension
  12. digital.ahrq.gov/sites/default/files/docs/publication/r18hs017035-mehr-final-report-2011.pdf
    January 01, 2011 - reports were planned for several chronic conditions, including also coronary artery disease (CAD), hypertension … clinics were identified by reports generated from the EMR every two weeks with established diabetes and hypertension … study of remote electronic monitoring entirely concerned chronically ill patients with diabetes and hypertension
  13. hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2021_Core.PDF
    January 01, 2021 - 0.06% 302: ATHEROSCLEROSIS WITH MCC 1,308 0.02% 303: ATHEROSCLEROSIS WITHOUT MCC 5,070 0.08% 304: HYPERTENSION … WITH MCC 8,060 0.12% 305: HYPERTENSION WITHOUT MCC 16,810 0.25% 306: CARDIAC CONGENITAL AND VALVULAR
  14. hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2020_Core_V2.PDF
    January 01, 2020 - 0.06% 302: ATHEROSCLEROSIS WITH MCC 1,301 0.02% 303: ATHEROSCLEROSIS WITHOUT MCC 5,101 0.08% 304: HYPERTENSION … WITH MCC 7,580 0.12% 305: HYPERTENSION WITHOUT MCC 16,342 0.25% 306: CARDIAC CONGENITAL AND VALVULAR
  15. hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2022_Core.PDF
    January 01, 2022 - 0.06% 302: ATHEROSCLEROSIS WITH MCC 1,354 0.02% 303: ATHEROSCLEROSIS WITHOUT MCC 4,870 0.07% 304: HYPERTENSION … WITH MCC 8,508 0.13% 305: HYPERTENSION WITHOUT MCC 17,197 0.26% 306: CARDIAC CONGENITAL AND VALVULAR
  16. hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_Core_Weighted_V2.PDF
    January 01, 2019 - 25,025 0.07% 302: ATHEROSCLEROSIS W MCC 7,263 0.02% 303: ATHEROSCLEROSIS W/O MCC 31,693 0.09% 304: HYPERTENSION … W MCC 43,198 0.12% 305: HYPERTENSION W/O MCC 107,332 0.30% 306: CARDIAC CONGENITAL & VALVULAR DISORDERS
  17. hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2021_CORE.PDF
    January 01, 2021 - 0.06% 302: ATHEROSCLEROSIS WITH MCC 3,535 0.02% 303: ATHEROSCLEROSIS WITHOUT MCC 13,926 0.08% 304: HYPERTENSION … WITH MCC 22,076 0.13% 305: HYPERTENSION WITHOUT MCC 47,565 0.28% 306: CARDIAC CONGENITAL AND VALVULAR
  18. hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2018_Core.PDF
    January 01, 2018 - 15,023 0.08% 302: ATHEROSCLEROSIS W MCC 4,238 0.02% 303: ATHEROSCLEROSIS W/O MCC 18,997 0.11% 304: HYPERTENSION … W MCC 22,377 0.13% 305: HYPERTENSION W/O MCC 56,324 0.32% 306: CARDIAC CONGENITAL & VALVULAR DISORDERS
  19. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_V2.PDF
    January 01, 2019 - CC/MCC 442 0.01% 302: ATHEROSCLEROSIS W MCC 32 0.00% 303: ATHEROSCLEROSIS W/O MCC 70 0.00% 304: HYPERTENSION … W MCC 334 0.01% 305: HYPERTENSION W/O MCC 782 0.03% 306: CARDIAC CONGENITAL & VALVULAR DISORDERS W
  20. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2022_MaskedStats_Core_Weighted.PDF
    January 01, 2022 - .**% 303: ATHEROSCLEROSIS WITHOUT MCC 64 0.00% 304: HYPERTENSION WITH MCC 499 0.01% 305: HYPERTENSION